|
CN102227447A
|
|
Cd86 antagonist multi-target binding proteins
|
|
MX2010011057A
|
|
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof.
|
|
WO2009023386A2
|
|
Binding peptides having a c-terminally disposed specific binding domain
|
|
US2009041765A1
|
|
Materials and methods for improved immunoglycoproteins
|
|
US2008279850A1
|
|
B-Cell Reduction Using CD37-Specific and CD20-Specific Binding Molecules
|
|
TW200848431A
|
|
Single-chain multivalent binding proteins with effector function
|
|
MX2009004170A
|
|
A method for increasing antibody-dependent cytotoxicity with castanospermine.
|
|
CN101490085A
|
|
Single-chain multivalent binding proteins with effector function
|
|
WO2007121354A2
|
|
Binding proteins comprising immunoglobulin hinge and fc regions having altered fc effector functions
|
|
CN101267836A
|
|
Single dose use of CD20-specific binding molecules
|
|
AU2006272714A1
|
|
Compositions and methods for protein deaggregation
|
|
CN101124248A
|
|
Binding domain fusion proteins
|
|
AU2003264021A1
|
|
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
|
|
Binding constructs and methods for use thereof
|
|
EP1537219A2
|
|
Activation of tumor-reactive lymphocytes via antibodies or genes recognizing cd3 or 4-1bb
|
|
US2003118592A1
|
|
Binding domain-immunoglobulin fusion proteins
|
|
MXPA03006358A
|
|
Binding domain-immunoglobulin fusion proteins.
|
